GL1X · GenesisL1 explorer

Research workbench

Human serum albumin-palmitic acid-FE(HN3PIT)CL2

Analyse Human serum albumin-palmitic acid-FE(HN3PIT)CL2 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5GIX
Type
protein
Length
1,162 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Serum albumin
UniProt
P02768
Ligands
PLM, 6WF
Pockets
11 · best druggability 0.91

Structure

x-ray diffraction · 1 distinct chain · 74% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BSerum albuminprotein58174% helix, 0% strandP02768

Ligands and binding sites

  • PLM · Palmitic acid · ligand · 12 copies · chains A, B
  • 6WF · 14-piperidin-1-yl-11-oxa-13$l^{3}-thia-15,16$l^{4}-diaza-12$l^{3}-ferratetracyclo[8.7.0.0^{2,7}.0^{12,16}]heptadeca-1(10),2(7),3,5,8,13,16-heptaene · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 9 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111110.910.931226WF, PLM
210950.890.901176WF, PLM
39330.770.7988PLM
46690.760.8259PLM
53390.730.8536PLM

Interfaces

1 interface between chains.

  • A–B · 251 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 34 disulfide, 3 lipid, 1 covalent (disulfide, palmitoylation, covalent ligand).

Compared structures

  • 5GIX · Human serum albumin-Palmitic acid-Fe(Hn3piT)Cl2 · the same entry in another collection · chain A against A, TM-score 1.00
  • P02768 · AlphaFold monomer V2.0 prediction for albumin (P02768) · a predicted model of the same protein · chain A against A, TM-score 0.85

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.